Antitumor activity of novel and potent YAP/TAZ-TEAD inhibitorstargeting the Hippo pathway in solid tumors

被引：1
|
作者：
Kim, Jisook
Jung, Seung Hyun
Han, Seon Yeong
Yoon, Jihee
Kim, Minjeong
Byun, Jooyun
Moon, Heesun
Lee, Eunyoung
Kim, Yu-Yon
Park, Hyunjin
Jeon, Ye
Ahn, Young Gil
Kim, Young Hoon
Suh, Kwee Hyun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1614
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1614
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review
    Crawford, James J.
    Bronner, Sarah M.
    Zbieg, Jason R.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (12) : 867 - 873
  • [2] Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers
    Luo, Mengxin
    Xu, Yongjin
    Chen, Haifeng
    Wu, Yiquan
    Pang, Ao
    Hu, Junjie
    Dong, Xiaowu
    Che, Jinxin
    Yang, Haiyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [3] Distinct effects of Hippo-YAP/TAZ and YAP/TAZ-TEAD in epithelial maintenance and repair
    Yuan, Qiuyun
    Yuan, Yao
    Peng, Yang
    Xia, Xiaoqiang
    Chen, Qianming
    Yu, Fa-Xing
    Feng, Xiaodong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 751
  • [4] Discovery of novel potent allosteric inhibitors of YAP/TAZ-TEAD transcription for the treatment of multiple solid tumor types addicted to Hippo signaling
    Versele, Matthias
    Candi, Aurelie
    Nijs, Marnik
    Haeck, Wanda
    Klaassen, Hugo
    Smets, Wim
    Spieser, Stephane
    Vanderhoydonck, Bart
    Marchand, Arnaud
    Chaltin, Patrick
    Sansores, Leticia
    Halder, Georg
    CANCER RESEARCH, 2020, 80 (16)
  • [5] The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
    Mokhtari, Reza Bayat
    Ashayeri, Neda
    Baghaie, Leili
    Sambi, Manpreet
    Satari, Kosar
    Baluch, Narges
    Bosykh, Dmitriy A. A.
    Szewczuk, Myron R. R.
    Chakraborty, Sayan
    CANCERS, 2023, 15 (13)
  • [6] The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
    Santucci, Matteo
    Vignudelli, Tatiana
    Ferrari, Stefania
    Mor, Marco
    Scalvini, Laura
    Bolognesi, Maria Laura
    Uliassi, Elisa
    Costi, Maria Paola
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) : 4857 - 4873
  • [7] Discovery of ETS-003, a potent and selective YAP/TAZ-TEAD PPI inhibitor with broad anti-tumor activity in Hippo-YAP aberrant cancers
    Lu, Jiajun
    Gao, Ming
    He, Hao
    Feng, Lijian
    Gao, Zhenting
    Cui, Wenqi
    Yang, Kun
    Lu, Jiting
    Zheng, Qiangang
    Zhu, Jidong
    Guo, Xin
    CANCER RESEARCH, 2023, 83 (07)
  • [8] The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
    Cunningham, Richard
    Hansen, Carsten Gram
    CLINICAL SCIENCE, 2022, 136 (03) : 197 - 222
  • [9] Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway
    Miesfeld, Joel B.
    Link, Brian A.
    MECHANISMS OF DEVELOPMENT, 2014, 133 : 177 - 188
  • [10] Targeting the YAP/TAZ-TEAD pathway with TEAD inhibitors synergizes with chemotherapy and blocks diffuse gastric cancer progression
    Bulakhova, Anastasiia
    Cho, Jin Sun
    Rifkin, Jack T.
    Kim, Jaewon
    Ryan, Thomas J.
    Tang, Tracy T.
    Moy, Ryan H.
    CANCER RESEARCH, 2024, 84 (06)
12345